ScreenerHero

QDEL QuidelOrtho Corporation

NAS · US · Healthcare · Medical Devices · quidelortho.com
12.31USD-2.07%Mkt Cap: 844.16M $P/E: —

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical ch…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$171.97BUSDP/E 31.8
MDT
Medtronic plc
$109.38BUSDP/E 21.0
SYK
Stryker Corporation
$105.64BUSDP/E 28.5
BSX
Boston Scientific Corporation
$60.26BUSDP/E 16.8
EW
Edwards Lifesciences Corporation
$49.39BUSDP/E 51.1
SHL
Siemens Healthineers AG
$46.91BUSDP/E 19.6
DXCM
DexCom, Inc.
$31.81BUSDP/E 33.5
GEHC
GE HealthCare Technologies Inc.
$29.42BUSDP/E 14.9
PHG
Koninklijke Philips N.V.
$23.55BUSDP/E 18.0
PHIA
Koninklijke Philips N.V.
$22.87BUSDP/E 18.7
STE
STERIS plc
$20.44BUSDP/E 25.6
SOON
Sonova Holding AG
$17.11BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$16.88BUSDP/E 21.5
PEN
Penumbra, Inc.
$12.46BUSDP/E 77.7
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
GKOS
Glaukos Corporation
$10.16BUSD
DEMANT
Demant A/S
$9.87BUSDP/E 28.0
TXG
10x Genomics, Inc.
$9.92BUSD
GMED
Globus Medical, Inc.
$9.90BUSDP/E 18.9
BIO
Bio-Rad Laboratories, Inc.
$9.85BUSDP/E 46.6

Key Statistics

Company
Market Cap844.16M USD
Enterprise Value3.81B USD
Revenue (TTM)2.67B USD
Gross Profit1.27B USD
Net Income (TTM)-1.13B USD
Revenue/Share39.27 USD
Last Price12.31 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.72
PEG2.06
EV/EBITDA7.87
EV/Revenue1.43
P/S0.32
P/B0.48
EPS (TTM)-15.39
EPS (Forward)1.44
52W Range
9.9209% of range35.58
52W High35.58 USD
52W Low9.920 USD
Profitability
Gross Margin46.67%
Oper. Margin-2.09%
EBITDA Margin18.12%
Profit Margin-41.45%
ROE-58.93%
ROA-19.62%
Growth
Revenue Growth2.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF105.20M USD
CapEx (TTM)188.20M USD
FCF Margin5.49%
FCF Yield17.39%
Net Debt2.95B USD
Net Debt/EBITDA6.09
Balance Sheet
Debt/Equity1.48
Current Ratio1.39
Quick Ratio0.60
Book Value/Sh25.99 USD
Cash/Share1.80 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.67 USD
Upside (mean)+19.1%
Target Range12.00 USD – 20.00 USD
12.00+19.1% to mean20.00
# Analysts3
Ownership
Shares Out.68.58M
Float61.17M
Insiders0.90%
Institutions124.14%
Short Interest
Short Ratio10.4d
Short % Float28.21%
Short % Out.20.69%
Shares Short14.19M
Short (prev mo.)14.96M
Technical
SMA 5013.43 (-8.4%)
SMA 20017.81 (-30.9%)
Beta0.78
S&P 52W Chg16.45%
Avg Vol (30d)1.57M
Avg Vol (10d)1.81M
Technical Indicators
RSI (14)51.0
MACD-0.5964
MACD Signal-0.9140
MACD Hist.+0.3176
BB Upper13.61 USD
BB Middle11.47 USD
BB Lower9.337 USD
BB Width37.25%
ATR (14)0.8401 USD
Vol Ratio (20d)1.53x